Ground Report | New Delhi: Covid vaccine for children in India; Serum American company Novavax is testing the vaccine for children aged 7-11 years. The serum is making this vaccine in India under the name Covavax. Schools that have been closed for about one and a half years in India are now slowly being opened and the need to vaccinate children is also being emphasized.
Regarding this trial of a vaccine for children, a committee of experts from the Central Drugs Standard Control Organization said, “After detailed discussion, the committee decided to allow children in the age group of 7 to 11 years to be admitted for the trial according to the protocol. recommended.”
Waiting for children’s vaccinations
- The Serum is already testing Covovax on 12-17-year-olds and has also represented safety data for the initial 100 participants.
- This vaccine has not yet been approved by the health agencies of the Government of India.
- At least the first dose has been given to about 87 crore adults in the country’s 1.4 billion population.
- A few days ago, Serum Institute owner Adar Poonawalla said that he was expecting Covovax to be approved for people under 18 by January or February next year.
- So far only Zydus Cadila’s DNA Covid-19 vaccine has been given emergency approval to be given to children above 12 years in India.
Covid vaccine for children
- Novavax last year announced a license agreement with Serum to produce Covovax in middle- and low-income countries.
- The serum has selected 10 Indian institutions for the trial of Covaxin.
- A total of 920 participants will participate in this trial.
Apart from this, Serum is also making the Russian vaccine Sputnik Lite and Poonawalla has said that his company will also start commercial production after getting its license in India.
Meanwhile, in India, the number of daily Covid-19 infection cases reported on 28 September recorded the lowest increase since March 2021. Only 18,795 new cases and 179 deaths were recorded in a day.